三金药业品牌怎么样 申请店铺

我要投票 三金药业在牙粉行业中的票数:863 更新时间:2026-02-17
三金药业是哪个国家的品牌?「三金药业」是 桂林三金药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人邹节明在1994期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力三金药业品牌出海!将品牌入驻外推网,定制三金药业品牌推广信息,可以显著提高三金药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

三金药业怎么样

桂林三金药业股份有限公司是三金集团的核心企业,主营中成药、天然药物的研发和生产,是国内最早生产现代中药制剂的厂家之一。1985年以来,桂林三金坚持改革创新,依靠科技进步和科学管理,主要经济指标以30%左右的年均速度递增,2009年,公司实现营业收入11.10亿元、利润总额3.77亿元,均同比增长10%以上,主要经济指标连续多年居广西医药行业首位,并位列中国中药行业50强前列,曾先后荣获全国质量效益型先进企业、全国企业管理杰出贡献奖、全国“五一”劳动奖状、全国思想政治工作优秀企业、全国文明单位、全国中药行业优秀企业等荣誉。

中药是国粹,作为地道的广西药企和传统产业中的一员,三金在崛起之初,就确立了“继承不泥古,发扬不离宗”的研发方向,并坚持以中医药理论为指导,现代科技为手段,依托广西本地资源,摒弃低水平仿制的老路,自主创新独家特色产品,创自己的名牌。目前,三金已成为区内外知名的高新技术企业,创新体系完备,研发投入充足,研发实力强劲,拥有国家级技术中心和博士后科研工作站,公司现有特色中药新药基本均由企业技术中心为主导研制,拥有自主知识产权,获国家中药发明专利或国家中药保护品种20余项。目前,三金在咽喉、口腔用药和泌尿系统用药方面已形成较强的专业和市场优势,代表产品三金西瓜霜系列、三金片成为全国同类中药的第一品牌,“三金”牌商标被国家工商行政总局认定为“驰名保护”,“三金”牌产品已行销海内外,并享有良好声誉。

多年来,三金一直坚持以产品经营为主,资本经营为辅的策略,在管理上,坚持推行“哑铃型”管理模式,不断引入国际、国内同行业的高标准,积极提高企业整体素质;目前,公司及下属药业类子公司已全面通过国家FSDA的GMP认证,企业竞争实力得到进一步增强。

目前,三金已成功进入国内资本市场,并积极响应桂林市委、市政府“向西发展,再造一个新桂林”的号召,开始了再创业的新征程,面向未来,我们将继续秉承“泽及生命、关爱健康、药精济世、忠实科学”的宗旨,因企制宜,不断创新,将三金建成国内领先、世界一流的中成药、天然药物研发生产企业,积极推动中药产业现代化与国际化,并有效提升对地方经济的贡献率,拉动相关产业发展。

Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin group, which is mainly engaged in the research and development and production of Chinese patent medicine and natural medicine. It is one of the earliest manufacturers of modern Chinese medicine preparations in China. Since 1985, Guilin Sanjin has been insisting on reform and innovation, relying on scientific and technological progress and scientific management, and its main economic indicators have increased at an average annual rate of about 30%. In 2009, the company achieved an operating revenue of 1.11 billion yuan and a total profit of 377 million yuan, with a year-on-year growth of more than 10%. Its main economic indicators have ranked the first in Guangxi's pharmaceutical industry for many years in a row, and ranked among the top 50 Chinese medicine industries It has won the honors of national advanced enterprise of quality and benefit, national outstanding contribution award of enterprise management, national "May 1st" labor certificate, national excellent enterprise of Ideological and political work, national civilized unit, national excellent enterprise of traditional Chinese medicine industry, etc. Traditional Chinese medicine is the quintessence of the country. As one of the authentic pharmaceutical enterprises and traditional industries in Guangxi, Sanjin established the research and development direction of "inheriting the ancient and developing the ancient", and insisted on taking the theory of traditional Chinese medicine as the guidance, modern technology as the means, relying on the local resources of Guangxi, abandoning the old way of low-level imitation, innovating the exclusive characteristic products independently and creating its own brand. At present, Sanjin has become a well-known high-tech enterprise inside and outside the District, with complete innovation system, sufficient R & D investment and strong R & D strength. It has a national technology center and postdoctoral research workstation. The company's existing characteristic new Chinese medicine is basically guided by the enterprise technology center, with independent intellectual property rights, and has won more than 20 national invention patents or national protected varieties of Chinese medicine Item. At present, Sanjin has formed strong professional and market advantages in throat, oral medicine and urinary system medicine. Sanjin watermelon cream series and Sanjin tablet, the representative products, have become the first brand of the same kind of traditional Chinese medicine in China. The trademark of Sanjin is recognized as "well-known protection" by the State Administration for Industry and commerce. Sanjin brand products have been sold at home and abroad and enjoy a good reputation. Over the years, Sanjin has been adhering to the strategy of focusing on product management and complementing capital management. In terms of management, Sanjin adheres to the management mode of "dumbbell type", constantly introduces high standards of the same industry at home and abroad, and actively improves the overall quality of the enterprise. At present, the company and its pharmaceutical subsidiaries have fully passed the GMP certification of the national fsda, and the competitiveness of the enterprise has been further enhanced. At present, Sanjin has successfully entered the domestic capital market, and actively responded to the call of Guilin municipal Party committee and municipal government to "develop to the West and create a new Guilin", started a new journey of re entrepreneurship. Facing the future, we will continue to adhere to the tenet of "benefiting life, caring for health, medicine, economy, and science", and build Sanjin into a leading position in China due to enterprise conditions and continuous innovation The world-class R & D and production enterprises of traditional Chinese medicine and natural medicine actively promote the modernization and internationalization of traditional Chinese medicine industry, effectively improve the contribution rate to local economy, and promote the development of related industries.

本文链接: https://brand.waitui.com/a7171ed71.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

牙粉行业十大品牌
牙粉行业排行榜第1名 | 三金药业
三金药业
863
牙粉行业排行榜第2名 | 皓齿健
皓齿健
807
外推网广告位招租,每天只要9块9

7×24h 快讯

宇树科技王兴兴:今年宇树科技的目标出货量在1-2万台左右

宇树科技创始人王兴兴表示,此次参演的G1与H2人形机器人,其核心亮点在于全自主集群控制技术的首次亮相,实现全球第一次集群快速跑位,最快任意跑位速度可达4m/s。王兴兴预计,今年全世界人形机器人的出货量至少达到几万台,宇树科技的目标出货量在1-2万台左右。但他也指出,受限于具身智能大脑等技术瓶颈,人形机器人还处于应用早期。(财联社)

2小时前

消息称英国监管机构考虑调整规则以吸引中国企业上市

英国审计监管机构正在考虑调整会计规则,以鼓励中国公司赴伦敦上市。Financial Reporting Council周一表示,将就是否允许在中国注册的公司在伦敦发行全球存托凭证(GDR)时遵循中国的会计规则征询意见。全球存托凭证(GDR)是由银行发行、代表外国公司股票的凭证。根据该拟议的规则调整,中国公司在发行GDR时,将被允许在限定的一段时间内遵循中国的审计准则。根据现行规定,在伦敦发行GDR的中国实体需要遵循英国的会计准则。(新浪财经)

2小时前

千问:1.3亿人春节首次体验AI购物

2月17日大年初一凌晨,千问发布的数据显示,春节活动期间,全国超过1.3亿人第一次体验AI购物,说了50亿次“千问帮我”。过去两天,用户用AI买门票的订单环比增长22倍,AI订机票等交通票务单量增长超7倍。随着春节档电影上线,用户用AI买电影票的订单环比增长372倍,其中来自三四线城市的AI订单量更是暴涨782倍。所有AI订单中,近一半订单来自县城,近400万60岁以上用户体验了AI购物。

2小时前

今年已有143家企业递表港股IPO

Wind数据显示,2026年以来,已有143家企业完成了港股IPO递表,其中120家为首次递表。截至2月16日,港股市场仍有401宗新股申请仍在处理之中,包括4家已通过聆讯的企业。德勤中国资本市场服务部预测,2026年香港新股市场或更胜去年,料约160只新股融资不少于3000亿港元。一个值得关注的趋势是,近期在港股上市的科技类企业正在受到国内外长线资金追捧。例如澜起科技17家基石投资者共认购约4.50亿美元,其中包括瑞银资管、摩根大通资管这样的全球长线基金;以安本为代表的老牌长线欧洲资金;以及中邮理财、泰康人寿等内地传统长线资金。(证券时报)

2小时前

豆包:除夕当天AI互动总数达19亿

36氪获悉,2月16日,字节跳动旗下AI助手豆包与央视总台春晚联动。豆包方面披露,除夕当天豆包AI互动总数达19亿。数据显示,“豆包过年”活动在除夕帮助用户生成超过5000万张新春主题头像、生成超过1亿条新春祝福。

2小时前

本页详细列出关于三金药业的品牌信息,含品牌所属公司介绍,三金药业所处行业的品牌地位及优势。
咨询